Filing metadata

Accession number
0000950170-24-042625
Form type
Form 4
Filer
NGM BIOPHARMACEUTICALS INC
CIK
CIK 1426332
Filed
Apr 08, 2024
Reporting period
Mar 26, 2024
Description
Insider transaction

Explore SEC Filings Hub